Medstar Washington Hospital Center

Medstar Washington Hospital Center was paid $239.08M by Medicaid between Jan 2018 and Dec 2024, across 640 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 6.8% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	452,511	$22.37M
2019	495,840	$27.66M
2020	404,831	$23.06M
2021	477,717	$31.86M
2022	434,141	$52.99M
2023	315,085	$43.86M
2024incomplete	252,827	$37.28M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0463	Hospital outpatient clinic visit for assessment and management of a patient	6.8%	149,570	112,893	$16.25M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	6.6%	73,448	63,784	$15.70M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	6.5%	72,316	64,638	$15.58M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	6.0%	61,392	55,595	$14.25M
96361	Intravenous infusion, hydration; each additional hour	5.9%	27,064	21,449	$14.02M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	4.6%	56,675	50,138	$11.08M
99215	Doctor's office visit, returning patient (complex)Prolong outpt/office vis	4.5%	55,816	48,444	$10.83M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	3.9%	47,184	42,734	$9.38M
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	3.6%	48,508	37,892	$8.58M
J9271	Injection, pembrolizumab, 1 mg	3.3%	1,112	799	$7.99M
70450	Computed tomography, head or brain; without contrast material	2.0%	18,968	17,455	$4.70M
59025	Fetal non-stress test	1.9%	13,750	7,626	$4.48M

628 more codes

43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	1.4%	4,766	$3.41M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	1.4%	8,616	$3.34M
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	1.3%	12,712	$3.03M
99282	Emergency department visit for the evaluation and management, low to moderate severity	1.3%	17,145	$3.02M
74177	Computed tomography, abdomen and pelvis; with contrast material	1.2%	13,962	$2.86M
99281	Emergency department visit for the evaluation and management, self-limited or minor	1.1%	9,360	$2.53M
99203	Doctor's office visit, new patient (routine)	<1%	13,464	$2.34M
77412		<1%	7,816	$2.32M
99204	Doctor's office visit, new patient (more involved)	<1%	12,978	$2.32M
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	3,795	$2.22M
20610		<1%	5,786	$2.16M
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	2,541	$2.14M
78815	Positron emission tomography (PET) for limited area imaging	<1%	1,998	$1.98M
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	1,958	$1.89M
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	<1%	1,579	$1.66M
71275	Computed tomographic angiography, chest, with contrast material	<1%	5,330	$1.53M
S9480	Intensive outpatient psychiatric services, per diem	<1%	5,509	$1.53M
36902		<1%	873	$1.53M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	9,633	$1.47M
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	3,655	$1.45M
93798		<1%	5,728	$1.44M
96415		<1%	3,789	$1.42M
G0378	Hospital observation service, per hour	<1%	20,511	$1.39M
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	10,005	$1.38M
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	6,306	$1.36M
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	3,323	$1.25M
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	6,487	$1.22M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	11,840	$1.19M
92012	Ophthalmological services: medical examination and evaluation, intermediate, established patient	<1%	9,415	$1.15M
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	10,575	$1.11M
V5261	Hearing aid, digital, binaural, bte	<1%	537	$1.09M
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	6,228	$1.08M
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	7,254	$991K
77063	Screening digital breast tomosynthesis, bilateral	<1%	14,688	$991K
93976		<1%	5,026	$984K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	5,405	$901K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	13,017	$895K
92014	Ophthalmological services: medical examination and evaluation, comprehensive, established patient	<1%	8,723	$859K
99205	Prolong outpt/office vis	<1%	4,299	$805K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	1,356	$793K
76642		<1%	5,577	$776K
90853	Group psychotherapy (other than of a multiple-family group)	<1%	5,242	$723K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	3,838	$709K
93970		<1%	4,122	$694K
76830	Ultrasound, transvaginal	<1%	6,193	$668K
19083		<1%	532	$662K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	8,654	$656K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	3,027	$636K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	5,242	$621K
71046	Radiologic examination, chest; 2 views	<1%	37,372	$607K
74183		<1%	1,692	$605K
36821		<1%	217	$604K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	3,649	$580K
64483		<1%	638	$571K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	3,412	$549K
J9355	Injection, trastuzumab, excludes biosimilar, 10 mg	<1%	615	$546K
93971		<1%	4,817	$540K
72197		<1%	1,046	$530K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	1,434	$507K
72141		<1%	2,600	$501K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	1,127	$495K
J0897	Injection, denosumab, 1 mg	<1%	618	$470K
Q5118	Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg	<1%	250	$450K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	3,943	$439K
20550		<1%	1,165	$432K
77386		<1%	657	$416K
97165		<1%	3,046	$408K
97161		<1%	4,035	$401K
10060		<1%	1,451	$398K
71250		<1%	5,200	$396K
92557		<1%	4,900	$389K
Q0138	Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)	<1%	916	$373K
J2505	Injection, pegfilgrastim, 6 mg	<1%	296	$372K
G0257	Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility	<1%	1,693	$372K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	1,513	$369K
70491		<1%	1,592	$364K
90791	Psychiatric diagnostic evaluation	<1%	1,312	$360K
93922		<1%	3,360	$357K
78306		<1%	1,060	$353K
76536		<1%	2,573	$351K
93975		<1%	2,308	$351K
77336		<1%	3,311	$337K
92950		<1%	834	$329K
96367		<1%	3,491	$327K
77334		<1%	1,649	$311K
74174		<1%	1,717	$308K
73630		<1%	11,888	$304K
70544		<1%	1,189	$304K
80048	Basic metabolic panel (calcium, ionized)	<1%	78,841	$290K
76770		<1%	2,181	$289K
93925		<1%	1,985	$287K
36561		<1%	128	$279K
94660		<1%	1,008	$279K
90833	Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on)	<1%	2,335	$276K
90715		<1%	9,145	$274K
92083		<1%	4,702	$272K
31575		<1%	1,960	$264K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	7,680	$261K
J1453	Injection, fosaprepitant, 1 mg	<1%	1,977	$246K
J0881	Injection, darbepoetin alfa, 1 microgram (non-esrd use)	<1%	1,616	$246K
52000		<1%	270	$246K
76801		<1%	2,385	$244K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	3,690	$230K
76819	Fetal biophysical profile; without non-stress testing	<1%	3,194	$221K
92004	Ophthalmological services: medical examination and evaluation, comprehensive, new patient	<1%	2,658	$218K
31579		<1%	284	$213K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	5,663	$207K
73562		<1%	8,704	$199K
67028	Intravitreal injection of a pharmacologic agent	<1%	847	$195K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	49,094	$193K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	41,322	$192K
77062		<1%	3,137	$188K
12001		<1%	642	$181K
94060		<1%	1,591	$179K
70486		<1%	4,030	$177K
96040		<1%	577	$175K
73030		<1%	7,909	$170K
92550		<1%	1,672	$166K
80053	Comprehensive metabolic panel	<1%	51,823	$159K
72125	Computed tomography, cervical spine; without contrast material	<1%	4,679	$159K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	14,732	$159K
93017		<1%	2,112	$157K
72100		<1%	6,265	$156K
77080		<1%	2,999	$152K
90686		<1%	5,723	$149K
73560		<1%	5,852	$142K
70498		<1%	737	$137K
71271		<1%	974	$132K
69210		<1%	2,876	$131K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	16,595	$120K
73610		<1%	7,797	$119K
77470		<1%	273	$118K
Q3014	Telehealth originating site facility fee	<1%	9,417	$118K
75574		<1%	249	$117K
94726		<1%	2,477	$117K
97535	Self-care/home management training, each 15 minutes	<1%	1,187	$116K
77300		<1%	1,112	$111K
73130		<1%	7,349	$107K
73221		<1%	513	$106K
93320		<1%	471	$104K
97116		<1%	1,388	$103K
93880		<1%	952	$102K
70496		<1%	255	$100K
88341		<1%	2,723	$99K
92504		<1%	2,527	$97K
76813		<1%	1,881	$96K
83880		<1%	11,877	$94K
77061		<1%	1,649	$92K
93750		<1%	2,236	$90K
94010		<1%	880	$90K
J9312	Injection, rituximab, 10 mg	<1%	30	$87K
72110		<1%	2,741	$86K
73110		<1%	4,846	$85K
77065	Tomosynthesis, mammo	<1%	3,724	$83K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	<1%	57	$80K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	1,081	$79K
72040		<1%	2,472	$77K
20605		<1%	186	$77K
73502		<1%	5,631	$76K
62323		<1%	60	$76K
72131		<1%	1,574	$75K
90677		<1%	501	$75K
93296		<1%	1,477	$72K
93458		<1%	89	$72K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	845	$70K
12011		<1%	325	$70K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	23,994	$69K
73700		<1%	555	$69K
71045	Radiologic examination, chest; single view	<1%	15,377	$68K
J1750	Injection, iron dextran, 50 mg	<1%	985	$68K
77066	Tomosynthesis, mammo	<1%	4,464	$66K
96375	Therapeutic injection; each additional sequential IV push	<1%	26,341	$66K
76820		<1%	1,771	$65K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	500	$63K
86923		<1%	1,730	$62K
51705		<1%	493	$61K
12002		<1%	232	$60K
93613		<1%	15	$60K
92133		<1%	3,776	$58K
92020		<1%	595	$58K
49083		<1%	213	$55K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	<1%	257	$54K
V5020	Conformity evaluation	<1%	1,399	$52K
94729		<1%	2,469	$52K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	36,385	$51K
75561		<1%	80	$51K
C1776	Joint device (implantable)	<1%	293	$51K
76000		<1%	2,780	$50K
76821		<1%	1,591	$49K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	14,973	$47K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	128	$47K
73564		<1%	1,274	$47K
V5010	Assessment for hearing aid	<1%	1,210	$46K
90750		<1%	617	$45K
29581		<1%	188	$44K
88307		<1%	2,179	$44K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	126,830	$43K
31231		<1%	214	$43K
37607		<1%	84	$42K
76512		<1%	341	$41K
76775		<1%	293	$41K
V5011	Fitting/orientation/checking of hearing aid	<1%	1,364	$41K
43235		<1%	74	$41K
84484		<1%	41,368	$41K
92567		<1%	2,074	$40K
36830		<1%	55	$40K
95816		<1%	176	$40K
16020		<1%	218	$38K
74178		<1%	135	$38K
72050		<1%	1,161	$38K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	1,299	$37K
99201		<1%	263	$37K
73120		<1%	761	$37K
60100		<1%	43	$35K
36832		<1%	14	$35K
90792	Psychiatric diagnostic evaluation with medical services	<1%	104	$35K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	160	$35K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	159	$34K
93247		<1%	328	$32K
76870		<1%	489	$32K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	324	$32K
72070		<1%	1,519	$32K
90670		<1%	815	$31K
85379		<1%	6,139	$31K
72146		<1%	449	$31K
77049		<1%	52	$28K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	110	$27K
73590		<1%	3,914	$27K
77301		<1%	14	$27K
C9257	Injection, bevacizumab, 0.25 mg	<1%	43	$26K
C1769	Guide wire	<1%	8,011	$25K
93926		<1%	364	$25K
92136		<1%	711	$23K
73080		<1%	2,333	$23K
94618		<1%	130	$23K
64493		<1%	29	$22K
80076		<1%	10,812	$22K
M0245	Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring	<1%	73	$21K
77290		<1%	62	$21K
87040		<1%	2,735	$21K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	1,399	$20K
64454		<1%	31	$19K
29125		<1%	86	$18K
90656		<1%	734	$18K
15275		<1%	16	$18K
20553		<1%	50	$17K
36901		<1%	13	$17K
V5275	Ear impression, each	<1%	452	$17K
76827		<1%	605	$17K
83605		<1%	13,278	$16K
86850		<1%	13,069	$16K
76942		<1%	219	$16K
77002		<1%	109	$16K
90694		<1%	1,180	$16K
86900		<1%	14,862	$16K
73620		<1%	300	$16K
74018		<1%	996	$15K
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	<1%	3,625	$15K
73552		<1%	2,349	$15K
73522		<1%	406	$15K
36247		<1%	17	$15K
90836		<1%	136	$15K
59020		<1%	56	$15K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	1,428	$15K
73140		<1%	863	$14K
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	2,735	$14K
96401		<1%	717	$14K
82962		<1%	51,473	$14K
77280		<1%	98	$14K
V5264	Ear mold/insert, not disposable, any type	<1%	223	$13K
90732		<1%	889	$13K
M0239	Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring	<1%	82	$13K
96416		<1%	182	$13K
31720		<1%	1,052	$13K
72170		<1%	1,373	$12K
77001		<1%	152	$12K
73060		<1%	1,613	$12K
95819		<1%	58	$12K
90837	Psychotherapy session, about an hour	<1%	112	$12K
96376		<1%	14,414	$12K
99218		<1%	176	$12K
76937		<1%	318	$12K
80320		<1%	4,005	$12K
29515		<1%	47	$12K
92570		<1%	1,928	$11K
83735		<1%	31,483	$11K
A4648	Tissue marker, implantable, any type, each	<1%	1,025	$11K
73521		<1%	596	$11K
90834	Psychotherapy session, about 45 minutes	<1%	83	$10K
77338		<1%	27	$10K
93298		<1%	221	$10K
76641		<1%	53	$10K
85027		<1%	6,545	$10K
M0247	Intravenous infusion, sotrovimab, includes infusion and post administration monitoring	<1%	27	$10K
93460		<1%	19	$10K
70547		<1%	145	$9K
93325		<1%	421	$9K
78582		<1%	49	$9K
96368		<1%	1,027	$9K
36590		<1%	12	$9K
87086	Culture, bacterial; quantitative colony count, urine	<1%	8,124	$9K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	8,918	$9K
88312		<1%	5,348	$8K
77295		<1%	17	$8K
97802		<1%	59	$8K
97597		<1%	40	$8K
36905		<1%	14	$8K
92587		<1%	74	$8K
93923		<1%	33	$8K
72192		<1%	41	$8K
72128		<1%	522	$8K
92082		<1%	70	$8K
88304		<1%	1,383	$8K
73600		<1%	200	$7K
95913		<1%	55	$7K
81001		<1%	35,369	$7K
51702		<1%	701	$7K
73090		<1%	1,741	$7K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	1,808	$7K
92134		<1%	4,496	$7K
82803		<1%	7,285	$7K
J3489	Injection, zoledronic acid, 1 mg	<1%	112	$7K
80061	Lipid panel	<1%	3,319	$7K
88342		<1%	3,825	$7K
76514		<1%	405	$7K
88313		<1%	761	$7K
86901		<1%	14,873	$6K
83036	Hemoglobin; glycosylated (A1C)	<1%	9,005	$6K
64484		<1%	164	$6K
J7325	Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg	<1%	41	$6K
91322		<1%	190	$6K
96523		<1%	145	$6K
82375		<1%	7,316	$6K
85610		<1%	24,593	$5K
C1768	Graft, vascular	<1%	76	$5K
95886		<1%	31	$5K
99385		<1%	30	$5K
74220		<1%	102	$5K
84443	Thyroid stimulating hormone (TSH)	<1%	8,466	$5K
99386		<1%	44	$5K
90688		<1%	260	$5K
90838		<1%	47	$5K
90832	Psychotherapy session, about 30 minutes	<1%	60	$5K
11104		<1%	13	$4K
51798		<1%	1,481	$4K
G0121	Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk	<1%	14	$4K
90662		<1%	230	$4K
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	2,274	$4K
36430		<1%	33	$4K
92593		<1%	178	$4K
C1760	Closure device, vascular (implantable/insertable)	<1%	1,750	$4K
J3490	Unclassified drugs	<1%	14,037	$4K
84100		<1%	15,389	$4K
70487		<1%	13	$3K
86317		<1%	928	$3K
96417		<1%	3,197	$3K
36415	Collection of venous blood by venipuncture	<1%	26,984	$3K
88185		<1%	92	$3K
92511		<1%	13	$3K
74181		<1%	14	$3K
84703		<1%	13,033	$3K
51700		<1%	24	$3K
92591		<1%	123	$3K
83690		<1%	23,319	$3K
G2066	Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results	<1%	94	$3K
90651		<1%	20	$3K
C2623	Catheter, transluminal angioplasty, drug-coated, non-laser	<1%	14	$3K
87581		<1%	492	$3K
70480		<1%	14	$2K
82570		<1%	1,624	$2K
80329		<1%	114	$2K
71101		<1%	488	$2K
83615		<1%	3,351	$2K
84702		<1%	6,943	$2K
90746		<1%	128	$2K
82330		<1%	3,531	$2K
81025		<1%	16,944	$2K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	1,518	$2K
74240		<1%	12	$2K
90653		<1%	892	$2K
74022		<1%	586	$2K
93246		<1%	35	$2K
C1874	Stent, coated/covered, with delivery system	<1%	42	$2K
86592		<1%	1,083	$2K
87077		<1%	3,406	$2K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	61	$2K
74230		<1%	26	$2K
92588		<1%	27	$2K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	4,136	$2K
36591		<1%	288	$2K
G0297	Low dose ct scan (ldct) for lung cancer screening	<1%	86	$2K
81003		<1%	14,958	$2K
75635		<1%	12	$2K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	34,983	$1K
86141		<1%	2,406	$1K
G0379	Direct admission of patient for hospital observation care	<1%	58	$1K
72158		<1%	12	$1K
80164		<1%	312	$1K
77417		<1%	726	$1K
85730		<1%	4,031	$1K
73100		<1%	39	$1K
84439		<1%	1,654	$1K
90658		<1%	75	$1K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	3,696	$1K
92002		<1%	12	$1K
80185		<1%	140	$1K
76882		<1%	13	$1K
82607		<1%	1,285	$1K
73070		<1%	12	$1K
73200		<1%	14	$1K
82728		<1%	1,232	$1K
84550		<1%	1,951	$1K
92611		<1%	44	$965.63
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	26,680	$930.28
99152		<1%	1,795	$929.84
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	528	$866.20
90678		<1%	14	$855.06
C1726	Catheter, balloon dilatation, non-vascular	<1%	471	$840.44
46600		<1%	603	$834.29
88184		<1%	97	$827.47
80050	General health panel	<1%	66	$825.38
96402		<1%	706	$823.96
87070		<1%	3,012	$815.10
84156		<1%	1,270	$753.40
90739		<1%	28	$748.71
87081		<1%	268	$712.78
93282		<1%	54	$693.96
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	4,102	$690.56
87186		<1%	3,255	$686.14
74019		<1%	47	$685.78
70490		<1%	18	$683.27
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	469	$679.99
82550		<1%	2,158	$656.46
88172		<1%	1,010	$649.70
97166		<1%	12	$649.28
C9290	Injection, bupivacaine liposome, 1 mg	<1%	683	$641.86
93350		<1%	70	$641.76
G0008	Administration of influenza virus vaccine	<1%	3,001	$619.91
92555		<1%	50	$618.92
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	29	$579.10
0352U		<1%	16	$554.70
82947		<1%	5,501	$539.63
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	11,864	$506.32
89051		<1%	425	$501.03
0124A		<1%	13	$466.40
85652		<1%	2,643	$464.86
92132		<1%	17	$448.62
87486		<1%	175	$441.28
90472	Immunization administration, each additional vaccine (list separately)	<1%	405	$440.86
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	777	$433.98
70355		<1%	485	$414.86
87340		<1%	1,167	$405.29
86360		<1%	37	$373.19
93280		<1%	28	$349.12
51703		<1%	49	$348.36
82077		<1%	3,792	$339.63
96409		<1%	216	$329.42
80047		<1%	41	$321.50
82270		<1%	1,173	$309.26
90480		<1%	194	$304.02
87899		<1%	369	$298.32
83540		<1%	847	$275.45
A9503	Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries	<1%	912	$275.40
87075		<1%	1,586	$239.55
84132		<1%	2,415	$236.82
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	9,858	$226.93
82248		<1%	923	$226.19
82746		<1%	522	$215.10
82010		<1%	586	$215.03
87205		<1%	2,358	$211.05
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	113	$208.19
J2785	Injection, regadenoson, 0.1 mg	<1%	1,181	$200.83
83550		<1%	574	$195.26
82820		<1%	2,221	$195.23
94762		<1%	749	$187.26
87428		<1%	390	$176.93
J1630	Injection, haloperidol, up to 5 mg	<1%	1,553	$175.92
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	<1%	1,259	$166.65
J1170	Injection, hydromorphone, up to 4 mg	<1%	6,638	$164.90
C1750	Catheter, hemodialysis/peritoneal, long-term	<1%	62	$159.94
88360		<1%	16	$155.19
91065		<1%	12	$150.67
J1650	Injection, enoxaparin sodium, 10 mg	<1%	11,299	$150.54
88112		<1%	103	$149.14
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	23,516	$146.76
85045		<1%	572	$142.41
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	<1%	16	$140.44
94760		<1%	1,635	$134.28
87147		<1%	318	$132.70
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	<1%	1,065	$114.14
82565		<1%	102	$106.48
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	8,751	$104.98
84295		<1%	2,187	$104.92
87480		<1%	39	$101.32
86870		<1%	28	$99.16
J1644	Injection, heparin sodium, per 1000 units	<1%	20,797	$94.35
C1733	Catheter, electrophysiology, diagnostic/ablation, other than 3d or vector mapping, other than cool-tip	<1%	309	$89.11
81002		<1%	1,113	$87.69
99153	Mod sedat endo service >5yrs	<1%	690	$87.63
J2704	Injection, propofol, 10 mg	<1%	27,846	$82.41
88311		<1%	136	$78.14
J2270	Injection, morphine sulfate, up to 10 mg	<1%	9,060	$71.08
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	473	$67.20
88173		<1%	1,081	$57.04
87510		<1%	39	$54.44
86140		<1%	299	$53.98
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	30	$53.20
85014		<1%	341	$49.50
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	7,817	$48.43
J3411	Injection, thiamine hcl, 100 mg	<1%	2,152	$47.95
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	2,102	$47.49
87660		<1%	39	$46.88
84520		<1%	99	$41.46
80074		<1%	61	$40.22
J7799	Noc drugs, other than inhalation drugs, administered through dme	<1%	1,444	$39.51
88302		<1%	80	$34.86
82436		<1%	46	$34.80
J7050	Infusion, normal saline solution, 250 cc	<1%	10,151	$32.49
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	22,368	$29.87
J1940	Injection, furosemide, up to 20 mg	<1%	3,800	$28.92
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	144	$27.25
J0690	Injection, cefazolin sodium, 500 mg	<1%	19,063	$23.82
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	4,014	$21.53
84133		<1%	45	$20.86
84300		<1%	88	$20.69
88108		<1%	38	$20.43
85384		<1%	16	$16.53
C9399	Unclassified drugs or biologicals	<1%	4,425	$16.52
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	2,076	$16.28
J7999	Compounded drug, not otherwise classified	<1%	4,625	$16.28
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	2,944	$15.27
J7030	Infusion, normal saline solution , 1000 cc	<1%	1,859	$14.83
J2060	Injection, lorazepam, 2 mg	<1%	3,241	$14.42
82150		<1%	13	$14.11
J7120	Ringers lactate infusion, up to 1000 cc	<1%	1,989	$11.81
87280		<1%	61	$11.81
J1790	Injection, droperidol, up to 5 mg	<1%	2,800	$10.30
87015		<1%	103	$10.13
J3475	Injection, magnesium sulfate, per 500 mg	<1%	4,656	$9.40
85008		<1%	19	$8.78
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	4,657	$5.34
J3370	Injection, vancomycin hcl, 500 mg	<1%	2,704	$4.88
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	4,175	$2.90
C9113	Injection, pantoprazole sodium, per vial	<1%	1,946	$2.00
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	1,423	$1.53
J9190	Injection, fluorouracil, 500 mg	<1%	360	$1.27
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	1,316	$1.05
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	5,684	$1.05
J0780	Injection, prochlorperazine, up to 10 mg	<1%	1,001	$0.96
J0456	Injection, azithromycin, 500 mg	<1%	540	$0.65
J3480	Injection, potassium chloride, per 2 meq	<1%	1,792	$0.49
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	1,330	$0.26
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	1,583	$0.08
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	0%	2,011	$0.00
C1758	Catheter, ureteral	0%	487	$0.00
C1729	Catheter, drainage	0%	445	$0.00
A4216	Sterile water, saline and/or dextrose, diluent/flush, 10 ml	0%	2,497	$0.00
J2550	Injection, promethazine hcl, up to 50 mg	0%	580	$0.00
J0688	Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg	0%	150	$0.00
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	0%	809	$0.00
J0640	Injection, leucovorin calcium, per 50 mg	0%	113	$0.00
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	799	$0.00
J1953	Injection, levetiracetam, 10 mg	0%	349	$0.00
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	0%	999	$0.00
J1580	Injection, garamycin, gentamicin, up to 80 mg	0%	213	$0.00
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	0%	227	$0.00
Q9957	Injection, perflutren lipid microspheres, per ml	0%	146	$0.00
0272		0%	482	$0.00
64495		0%	29	$0.00
J3371	Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mg	0%	87	$0.00
C1757	Catheter, thrombectomy/embolectomy	0%	123	$0.00
C1788	Port, indwelling (implantable)	0%	100	$0.00
G8989	Self care functional limitation, discharge status, at discharge from therapy or to end reporting	0%	384	$0.00
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	0%	732	$0.00
82805		0%	123	$0.00
87102		0%	47	$0.00
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	0%	1,219	$0.00
51701		0%	31	$0.00
J0736	Injection, clindamycin phosphate, 300 mg	0%	92	$0.00
J1596	Injection, glycopyrrolate, 0.1 mg	0%	57	$0.00
A9575	Injection, gadoterate meglumine, 0.1 ml	0%	249	$0.00
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	0%	12	$0.00
C1751	Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)	0%	14	$0.00
J9263	Injection, oxaliplatin, 0.5 mg	0%	107	$0.00
80143		0%	17	$0.00
J1171	Injection, hydromorphone, 0.1 mg	0%	106	$0.00
93356		0%	14	$0.00
J0744	Injection, ciprofloxacin for intravenous infusion, 200 mg	0%	60	$0.00
80179		0%	15	$0.00
J0670	Injection, mepivacaine hydrochloride, per 10 ml	0%	15	$0.00
J3260	Injection, tobramycin sulfate, up to 80 mg	0%	13	$0.00
C1766	Introducer/sheath, guiding, intracardiac electrophysiological, steerable, other than peel-away	0%	668	$0.00
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	0%	620	$0.00
0270		0%	196	$0.00
G8987	Self care functional limitation, current status, at therapy episode outset and at reporting intervals	0%	676	$0.00
J0461	Injection, atropine sulfate, 0.01 mg	0%	126	$0.00
J9045	Injection, carboplatin, 50 mg	0%	673	$0.00
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	0%	37	$0.00
J2795	Injection, ropivacaine hydrochloride, 1 mg	0%	749	$0.00
96411		0%	593	$0.00
C1819	Surgical tissue localization and excision device (implantable)	0%	420	$0.00
J0610	Injection, calcium gluconate (fresenius kabi), per 10 ml	0%	309	$0.00
0250		0%	1,359	$0.00
0370		0%	349	$0.00
V2632	Posterior chamber intraocular lens	0%	454	$0.00
0721		0%	192	$0.00
C1773	Retrieval device, insertable (used to retrieve fractured medical devices)	0%	310	$0.00
0710		0%	333	$0.00
G8988	Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	632	$0.00
G8980	Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting	0%	427	$0.00
J2003	Injection, lidocaine hydrochloride, 1 mg	0%	275	$0.00
G0009	Administration of pneumococcal vaccine	0%	622	$0.00
C1781	Mesh (implantable)	0%	27	$0.00
J1920	Injection, labetalol hydrochloride, 5 mg	0%	180	$0.00
J9267	Injection, paclitaxel, 1 mg	0%	477	$0.00
J2780	Injection, ranitidine hydrochloride, 25 mg	0%	28	$0.00
C1892	Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, peel-away	0%	16	$0.00
C2617	Stent, non-coronary, temporary, without delivery system	0%	57	$0.00
A9558	Xenon xe-133 gas, diagnostic, per 10 millicuries	0%	41	$0.00
J1030	Injection, methylprednisolone acetate, 40 mg	0%	213	$0.00
A9540	Technetium tc-99m macroaggregated albumin, diagnostic, per study dose, up to 10 millicuries	0%	60	$0.00
C1732	Catheter, electrophysiology, diagnostic/ablation, 3d or vector mapping	0%	15	$0.00
64494		0%	29	$0.00
J2470	Injection, pantoprazole sodium, 40 mg	0%	17	$0.00
96377		0%	34	$0.00
C1730	Catheter, electrophysiology, diagnostic, other than 3d mapping (19 or fewer electrodes)	0%	16	$0.00
88300		0%	17	$0.00
J2373	Injection, phenylephrine hydrochloride (immphentiv), 20 micrograms	0%	19	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBARASH, AMANDA (CFO)